In a report issued on June 24, Marie Thibault from BTIG maintained a Buy rating on Irhythm Technologies (IRTC – Research Report), with a price target of $155.00. The company's shares closed last Friday at $115.62. According to TipRanks.com, Thibault is a 4-star analyst with an average return of 6.2% and a 27.2% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Boston Scientific. Currently, the analyst consensus on Irhythm Technologies is a Moderate Buy with an average price target of $157.71, which is a 43.5% upside from current levels.
https://www.tipranks.com/news/blurbs/irhythm-technologies-irtc-gets-a-buy-rating-from-btig?utm_source=advfn.com&utm_medium=referral
iRhythm Technologies (NASDAQ:IRTC)
Historical Stock Chart
From Mar 2023 to Apr 2023 Click Here for more iRhythm Technologies Charts.
iRhythm Technologies (NASDAQ:IRTC)
Historical Stock Chart
From Apr 2022 to Apr 2023 Click Here for more iRhythm Technologies Charts.